Akce, M., Morgan, C., Ozluk, A. A., Hussaini, S. Q., Gupta, G., Outlaw, D. A., Bray, A., Malla, M., El-Rayes, B. F. (2026). A phase Ib/II, dose escalation and dose expansion study of valemetostat tosylate (DS-3201b) with atezolizumab and bevacizumab in advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps613